Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS)

Prenatal Diagnosis

Volumn 27, Issue 5, 2007, Pages 409-414

  Craig, Wendy Y ^a   Haddow, James E ^a,b   Palomaki, Glenn E ^b   Roberson, Marie ^c  

^a Foundation for Blood Research   (United Kingdom)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c STATE OF CALIFORNIA   (United States)

Author keywords

Counseling and diagnosis; Other anatomic chromosomal abnormalities; Smith Lemli Optiz syndrome

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ALGORITHM; ANENCEPHALUS; ANEUPLOIDY; ARTICLE; CARDIOPULMONARY ARREST; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; FETUS DEATH; FETUS DISEASE; GASTROSCHISIS; GENETIC COUNSELING; HOLOPROSENCEPHALY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; PARTIAL TRISOMY 9; PATIENT COUNSELING; PREGNANCY OUTCOME; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SMITH LEMLI OPITZ SYNDROME; TRIPLOIDY; TRISOMY 18; TURNER SYNDROME; ADULT; BLOOD; EVALUATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY; PREDICTION AND FORECASTING; PREGNANCY; PRENATAL DIAGNOSIS; UNITED STATES;

ADULT; ALPHA-FETOPROTEINS; CALIFORNIA; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NEURAL TUBE DEFECTS; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; SMITH-LEMLI-OPITZ SYNDROME;

EID: 34347209805     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1699     Document Type: Article

References (14)

1. Bradley LA, Canick JA, Palomaki GE, Haddow JE. 1997. Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency. Am J Obstet Gynecol 176: 531-535.
2. Bradley LA, Palomaki GE, Knight GJ. et al. 1999. Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. Am J Med Genet 82: 355-358.
3. Bullen PJ, Rankin JM, Robson SC. 2001. Investigation of the epidemiology and prenatal diagnosis of holoprosencephaly in the North of England. Am J Obstet Gynecol 184: 1256-1262.
4. California Code of Regulations. 1986. California Administrative Code Title 17.
5. Cameron FJ, Khadilkar VV, Stanhope R. 1999. Pituitary dysfunction, morbidity and mortality with congenital midline malformation of the cerebrum. Eur J Pediatr 158: 97-102.
6. Canick JA, Knight GJ, Palomaki GE, Haddow JE. 1990. Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida. Prenat Diagn 10: 733-737.
7. CDC. 2002. Vital and health statistics 2000-natality data set, Series 21, No. 14 [Database on CD-ROM]. Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.
8. Craig WY, Haddow JE, Palomaki GE, et al. 2006. Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome. Prenat Diagn 26: 842-849.
9. Ferguson-Smith MA, Yates JR. 1984. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52 965 amniocenteses. Prenat Diagn 4 Spec: 5-44.
10. Kjaer I, Fischer-Hansen B. 1995. Human fetal pituitary gland in holoprosencephaly and anencephaly. J Craniofac Genet Dev Biol 15: 222-229.
11. Kjaer I, Keeling JW, Reintoft I, et al. 1998. Pituitary gland and sella turcica in human trisomy 18 fetuses. Am J Med Genet 76: 87-92.
12. Palomaki GE, Bradley LA, Knight GJ, Craig WY, Haddow JE. 2002. Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome. J Med Screen 9: 43-44.
13. Palomaki GE, Haddow JE, Knight GJ, et al. 1995. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn 15: 713-723.
14. Wald NJ, Cuckle HS, Densem JW, et al. 1988. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297: 883-887.